Jeffrey A Cohen Selected Research

Interferon beta-1a

11/2019	Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (SUNBEAM): a multicentre, randomised, minimum 12-month, phase 3 trial.
11/2019	Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (RADIANCE): a multicentre, randomised, 24-month, phase 3 trial.
10/2019	Infection risk with alemtuzumab decreases over time: pooled analysis of 6-year data from the CAMMS223, CARE-MS I, and CARE-MS II studies and the CAMMS03409 extension study.
9/2017	Alemtuzumab CARE-MS II 5-year follow-up: Efficacy and safety findings.
1/2017	The EDSS-Plus, an improved endpoint for disability progression in secondary progressive multiple sclerosis.
11/2016	Alemtuzumab improves preexisting disability in active relapsing-remitting MS patients.
10/2016	Superior MRI outcomes with alemtuzumab compared with subcutaneous interferon β-1a in MS.
11/2014	The clinical meaning of walking speed as measured by the timed 25-foot walk in patients with multiple sclerosis.
11/2012	Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial.
11/2012	Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jeffrey A Cohen Research Topics

Disease

85	Multiple Sclerosis 10/2022 - 02/2005
19	Relapsing-Remitting Multiple Sclerosis 01/2022 - 11/2008
11	Infections 01/2022 - 02/2010
4	Macular Edema 06/2021 - 02/2010
4	Disease Progression 11/2019 - 10/2009
4	Atrioventricular Block 11/2019 - 02/2010
4	Pain (Aches) 06/2011 - 05/2003
3	Optic Neuritis (Retrobulbar Neuritis) 10/2021 - 01/2015
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2018 - 01/2007
3	Neoplasms (Cancer) 10/2017 - 03/2011
3	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2017 - 11/2012
3	Neuralgia (Stump Neuralgia) 03/2011 - 05/2003
3	Peripheral Nervous System Diseases (PNS Diseases) 03/2011 - 05/2003
2	Progressive Multifocal Leukoencephalopathy 01/2022 - 01/2017
2	COVID-19 01/2022 - 10/2021
2	Chronic Progressive Multiple Sclerosis 01/2020 - 01/2017
2	Urinary Tract Infections (Urinary Tract Infection) 11/2019 - 04/2016
2	Opportunistic Infections (Opportunistic Infection) 11/2019 - 01/2018
2	Atrophy 09/2017 - 04/2005
2	Papillary Carcinoma 01/2017 - 11/2012
2	Bradycardia 09/2014 - 02/2010
1	Respiratory Tract Infections (Respiratory Tract Infection) 11/2019
1	Human Influenza (Influenza) 11/2019
1	Autoimmune Diseases (Autoimmune Disease) 01/2019
1	Neuromuscular Diseases (Neuromuscular Disease) 01/2018
1	HIV Infections (HIV Infection) 01/2018
1	Merkel Cell Carcinoma 10/2017
1	Melanoma (Melanoma, Malignant) 01/2017
1	Metaplasia 04/2016
1	Nasopharyngitis 04/2016
1	Headache (Headaches) 04/2016
1	Crohn Disease (Crohn's Disease) 01/2015
1	Lymphoma (Lymphomas) 01/2015
1	Ophthalmoplegia (External Ophthalmoplegia) 07/2014
1	Spontaneous Abortion (Miscarriage) 02/2014
1	Inflammation (Inflammations) 10/2013
1	Brain Ischemia (Cerebral Ischemia) 02/2013
1	Demyelinating Diseases (Demyelinating Disease) 05/2012

Drug/Important Bio-Agent (IBA)

25	Fingolimod Hydrochloride (FTY720)FDA Link 01/2021 - 02/2010
12	Interferon beta-1a FDA Link 11/2019 - 02/2010
10	ozanimodIBA 10/2022 - 04/2016
9	Sphingosine-1-Phosphate ReceptorsIBA 10/2021 - 07/2015
9	Alemtuzumab (Campath)FDA Link 10/2019 - 11/2012
5	Glatiramer Acetate (Copaxone)FDA Link 10/2022 - 11/2008
5	InterferonsIBA 02/2021 - 02/2010
5	Monoclonal AntibodiesIBA 01/2021 - 11/2012
5	Dimethyl FumarateIBA 01/2020 - 11/2016
5	Pharmaceutical PreparationsIBA 01/2020 - 03/2011
4	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 04/2005
4	Biomarkers (Surrogate Marker)IBA 11/2021 - 07/2014
3	teriflunomideIBA 01/2022 - 01/2020
3	ofatumumab FDA Link 01/2022 - 01/2020
3	Natalizumab (Tysabri)FDA Link 01/2022 - 11/2014
3	ocrelizumabIBA 01/2021 - 11/2020
3	GadoliniumIBA 11/2019 - 02/2013
3	Interferon-betaIBA 08/2013 - 11/2008
2	Amantadine (Aman)FDA LinkGeneric 01/2022 - 01/2019
2	siponimodIBA 01/2021 - 01/2020
2	Rituximab (Mabthera)FDA Link 01/2021 - 01/2015
2	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 04/2016 - 07/2015
2	Antidepressive Agents (Antidepressants)IBA 06/2011 - 01/2007
2	Taxoids (Taxanes)IBA 03/2011 - 05/2010
1	Immunoglobulin G (IgG)IBA 01/2022
1	VaccinesIBA 01/2022
1	COVID-19 VaccinesIBA 01/2022
1	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2022
1	EpitopesIBA 01/2021
1	ublituximabIBA 01/2021
1	ponesimodIBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2020
1	evobrutinibIBA 01/2020
1	Biotin (Vitamin H)FDA Link 01/2020
1	Matrix Metalloproteinases (MMPs)IBA 01/2020
1	Cladribine FDA LinkGeneric 01/2020
1	Immunologic Factors (Immunomodulators)IBA 01/2020
1	laquinimodIBA 01/2020
1	Tyrosine (L-Tyrosine)FDA Link 01/2020
1	Minocycline (Cyclops)FDA LinkGeneric 01/2020
1	Acyclovir (Aciclovir)FDA LinkGeneric 10/2019
1	Biosimilar PharmaceuticalsIBA 10/2019
1	Oligoclonal BandsIBA 01/2018
1	Neuroprotective AgentsIBA 10/2017
1	ProstaglandinsIBA 11/2016
1	Bendamustine Hydrochloride FDA Link 01/2015
1	ibritumomab tiuxetan (Zevalin)FDA Link 01/2015
1	Retinaldehyde (Retinal)IBA 01/2015
1	4-Aminopyridine (4 Aminopyridine)FDA Link 07/2014
1	Histamine Antagonists (Antihistamines)IBA 01/2014

Therapy/Procedure

42	Therapeutics 01/2022 - 01/2007
6	Mesenchymal Stem Cell Transplantation 10/2019 - 10/2013
3	Drug Therapy (Chemotherapy) 01/2015 - 05/2010
2	Injections 01/2020 - 06/2015
2	Transplantation 01/2019 - 11/2017
1	Telescopes 10/2021
1	Shared Medical Appointments 09/2021
1	Kidney Transplantation 01/2021
1	Intravenous Infusions 10/2019
1	Retreatment 10/2019
1	Cell Transplantation 01/2019
1	Stem Cell Transplantation 11/2017